Syncora P/E
What is the P/E of Syncora?
The P/E of Syncora Holdings Ltd. is N/A
What is the definition of P/E?
Price to earnings ratio is the ratio of a company’s stock price to the company’s earnings per share calculated over trailing twelve months.
= previous day’s close / ttm EPS
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E of companies in the Finance sector on OTC compared to Syncora
What does Syncora do?
SHL Holdings Ltd. does not have significant operations. It was previously engaged in the provision of financial guarantee insurance and reinsurance, and credit enhancement for the obligations of debt issuers. The company was formerly known as Syncora Holdings Ltd. and changed its name to SHL Holdings Ltd. in December 2020. SHL Holdings Ltd. was founded in 2006 and is headquartered in Hamilton, Bermuda.
Companies with p/e similar to Syncora
- Scotgold Resources has P/E of N/A
- FSD Pharma Inc has P/E of N/A
- Revolution Bars Plc has P/E of N/A
- First Foods has P/E of N/A
- Tritent International has P/E of N/A
- Navidea Biopharmaceuticals Inc has P/E of N/A
- Syncora has P/E of N/A
- YogaWorks has P/E of N/A
- Naked Brand has P/E of N/A
- Andover Mining has P/E of N/A
- Le Chateau has P/E of N/A
- Bonavista has P/E of N/A
- Sorrento Therapeutics has P/E of N/A